Designing a weight loss program that will incorporate the latest compounded medications such as semaglutide (Ozempic) and tirzepatide(Mounjaro/Zepbound), requires a multifaceted approach focusing on medication management, lifestyle modifications, dietary changes, and regular monitoring.
Once deemed appropriate based on the medical assessment, Synergy Telehealth Doctors initiate treatment with semaglutide or tirzepatide. These medications are typically administered by subcutaneous injection and work by increasing feelings of fullness, reducing appetite, and improving glycemic control.
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.